Multi-event October 2015 FDA Recall Drug by Pacific Healthcare, Inc Dba B&b Pharmacy
This Multi-event Class II drug recall was voluntarily initiated by Pacific Healthcare, Inc Dba B&b Pharmacy on October 7, 2015 for the product Drug. The FDA reported the reason for recall as lack of assurance of sterility; fda inspection identified gmp violations potentially impacting product quality and sterility. The product was distributed in CA and NJ and the recall is currently terminated.
Reported Recall Events
D-0176-2016 D-0168-2016 D-0167-2016 D-0179-2016 D-0171-2016 D-0173-2016 D-0170-2016 D-0166-2016 D-0175-2016 D-0174-2016 D-0165-2016 D-0177-2016 D-0172-2016 D-0180-2016 D-0178-2016 D-0169-2016
Recall Number: D-0176-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1- 5ml vial, 1- 10 ml vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (15mg/5mcg/0.5mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 5 ml --- 07062015@1, exp 1/2/2016; ---- 10 ml --- 07272015@3, exp 1/23/2016
Recall Number: D-0168-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
2 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Testosterone prop. 200 mg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07282015@8, exp 10/26/2015, 07302015@4, exp 10/28/2015
Recall Number: D-0167-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
3 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Testosterone Cypionate 250 mg/mL Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07282015@7, exp 10/26/2015, 07292015@6, 10/27/2015, 08252015@4, 11/23/2015
Recall Number: D-0179-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (35mg/12mcg/1.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 08032015@4, exp 1/30/2016
Recall Number: D-0171-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
3 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PGE 20mcg/ml Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 05072015@7, exp 11/3/2015; 05182015@3, 11/14/2015; 07152015@, 1/11/2016
Recall Number: D-0173-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (22.5mg/8.33mcg/0.833mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 06012015@8, exp 11/28/2015
Recall Number: D-0170-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1-5 ml vial, 3-10 ml vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PHENTO (30mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 5 ml --- 07212015@2, exp 1/17/2016; 10 ml --- 05062015@17, exp 11/2/2015; 07082015@10, exp 1/4/2016; 08312015@3, exp 2/20/2016
Recall Number: D-0166-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
2-10ml vials, 1-20ml vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Nandrolone 200 mg/ml Injection, 10 mL and 20 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 10 ml-- 05252015@2, exp 10/23/2015; 06252015@2, exp 10/23/2015 20 mL-- 06252015@2, exp 10/23/2015
Recall Number: D-0175-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (30mg/40mcg/1mg/ml) Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07022015@3, exp 12/29/2015
Recall Number: D-0174-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1-5 ml vial; 3-10 ml vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (30mg/10mg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 5 ml --- 07062015@2, exp 1/2/2016 10 ml --- 06042015@4, exp 12/1/2015; 06052015@15, exp 12/2/2015; 07132015@3, exp 1/9/2016
Recall Number: D-0165-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
2 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Stanozolol 200 mg/ml Injection, 20 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07162015@3, exp 10/14/2015, 08112015@1, exp 11/9/2015
Recall Number: D-0177-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
4 vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PGE 30mcg/ml Injection, 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07062015@8, exp 1/2/2016; 07162015@7, exp 1/12/2016; 07272015@5, exp 1/23/2016; 08142015@9, exp 2/10/2016
Recall Number: D-0172-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PGE1/PHENTO (30mg/50mcg/0.5mg/ml), Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 06012015@7, exp 11/28/2015
Recall Number: D-0180-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PGE 25mcg/ml, Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 08242015@5, exp 2/20/2016
Recall Number: D-0178-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
1 vial
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA/PHENTO (15mg/0.8333mg/ml) Injection, 5 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 07082015@4, exp 1/5/2016
Recall Number: D-0169-2016
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
10-07-2015
11-18-2015
31 -10 ml vials; 16- 5 ml vials
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Pacific Healthcare, Inc dba B&B Pharmacy
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
CA and NJ
04-07-2016
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
PAPA+PGE1+PHENTO (30mg/20mcg/1mg/ml) Injection, 5 mL and 10 mL vials, Rx, B & B Health Mart Pharmacy, Bellflower, CA
Batch or Lot Expiration Information
Lot# 5 mL 06022015@11, exp 11/29/2015; 06082015@5, exp 12/5/2015; 06112015@7, exp 12/8/2015; 06112015@9, exp 12/8/2015; 06162015@7, exp 12/13/2015; 07092015@6, exp 1/5/2016; 07092015@7, exp 1/5/2016; 07162015@4, exp 1/12/2016; 07202015@1, exp 1/16/2016; 07202015@2, exp 1/16/2016; 08032015@6, exp 1/30/2016; 08142015@12, exp 2/10/2016; 08142015@13, exp 2/10/2016; 08142015@7, exp 2/10/2016; 08182015@14, exp 2/14/2016; 08242015@6, exp 2/20/2016 --- 10 mL 05042015@4, exp 10/31/2015; 06012015@6, exp 11/28/2015; 06022015@12, exp 11/29/2015; 06032015@5, exp 11/30/2015; 06082015@4, exp 12/5/2015; 06082015@5, exp 12/5/2015; 06112015@4, exp 12/8/2015; 06152015@10, exp 12/12/2015; 06162015@6, exp 12/13/2015; 06232015@12, exp 12/20/2015; 07012015@1, exp 12/28/2015; 07092015@8, exp 1/5/2016; 07132015@2, exp 1/9/2016; 07152015@10, exp 1/11/2016; 07162015@6, exp 1/12/2016; 07272015@4, exp 1/23/2016; 07282015@3, exp 1/24/2016; 07282015@4, exp 1/24/2016; 07282015@5, exp 1/24/2016; 07292015@4, exp1/25/2016; 08032015@2, exp 1/30/2016; 08032015@7, exp 1/30/2016; 08142015@10, exp 2/10/2016; 08142015@11, exp 2/10/2016; 08142015@2, exp 2/10/2016; 08142015@4, exp 2/10/2016; 08142015@6, exp 2/10/2016; 08142015@8, exp 2/10/2016; 08182015@12, exp 2/14/2016; 08182015@13, exp 2/14/2016; 08312015@4, exp 2/20/2016
